EnzyTag Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

EnzyTag General Information

Description

Developer of a peptide synthesis technology designed to assist in developing peptide-based new chemical entities and conjugates. The company's technology provides processes for both linear peptide drugs and antibody-drug conjugates, enabling clients to get traceless ligation of peptides and proteins at reduced synthesis lead time, lower cost, and higher volumetric productivity.

Contact Information

Website
www.enzytag.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Daelderweg 9
  • 6361 HK Nuth
  • Netherlands
+31 045
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Discovery Tools (Healthcare)
Corporate Office
  • Daelderweg 9
  • 6361 HK Nuth
  • Netherlands
+31 045

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EnzyTag Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Nov-2019 Completed Generating Revenue
To view EnzyTag’s complete valuation and funding history, request access »

EnzyTag Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

EnzyTag Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4122944-A1 Enzymatic synthesis of cyclic peptides Inactive 21-Jul-2021

EnzyTag Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EnzyTag Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brightlands Venture Partners Venture Capital Minority
Limburg Business Development Fund Venture Capital Minority
Limburg Development and Investment Company Government Minority
To view EnzyTag’s complete investors history, request access »

Ready to get started?

Request a free trial

EnzyTag FAQs

  • When was EnzyTag founded?

    EnzyTag was founded in 2018.

  • Where is EnzyTag headquartered?

    EnzyTag is headquartered in Nuth, Netherlands.

  • What is the size of EnzyTag?

    EnzyTag has 9 total employees.

  • What industry is EnzyTag in?

    EnzyTag’s primary industry is Biotechnology.

  • Is EnzyTag a private or public company?

    EnzyTag is a Private company.

  • What is EnzyTag’s current revenue?

    The current revenue for EnzyTag is .

  • Who are EnzyTag’s investors?

    Brightlands Venture Partners, Limburg Business Development Fund, and Limburg Development and Investment Company have invested in EnzyTag.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »